Spectral AI, Inc. MDAI

Competitive advantage analysis · healthcare

Medical Devices & Diagnostics
Overall moat score
42/100
Developing

About Spectral AI, Inc.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds … Full MDAI analysis →

Competitive advantage assessment

Key strengths

  • Stable Gross Margin Profile Gross margin stability is strong (score 0.84). Low volatility confirms durable consumable pricing.
  • Improving FCF Trend FCF trend score is positive (score 0.67). Improving FCF margin signals compounding operational leverage.

Key risks

  • Weak Capital Return Profile Capital return quality is below peers (score 0.08). Low ROIC raises questions about M&A discipline and pipeline ROI.
  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.28). May indicate commodity-like product mix or distributor margin drag.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
51

Where MDAI ranks in Medical Devices

Spectral AI, Inc. ranks #103 of 160 scored companies in Medical Devices by moat score — the top 64%. The widest moat in the group is iRadimed Corporation (IRMD) at 83/100.

Moat scores for companies ranked near MDAI in Medical Devices
# Company Moat score Rating
99 LENSAR, Inc. LNSR 43/100 Developing
100 ClearPoint Neuro Inc. CLPT 43/100 Developing
101 Nexalin Technology, Inc. NXL 43/100 Developing
102 MDAIW MDAIW 42/100 Developing
103 Spectral AI, Inc. MDAI 42/100 Developing
104 Myomo Inc. MYO 41/100 Developing
105 QuidelOrtho Corporation QDEL 40/100 Developing
106 Allurion Technologies, Inc. ALUR 39/100 Developing
107 Quanterix Corporation QTRX 39/100 Developing

See every Medical Devices & Diagnostics company ranked by moat score →

How MDAI scores on the Medical Devices & Diagnostics defenses

Pricing Power & Consumable Moat

Score 51 · 25% of the moat score

In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.

R&D Pipeline & Capital Returns

Score 9 · 20% of the moat score

Research spending is how a device company keeps its installed base current, but spending alone proves nothing.

FCF Quality & Cash Conversion

Score 52 · 20% of the moat score

MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.

Commercial Execution

Score 59 · 15% of the moat score

Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.

Capital Structure & Resilience

Score 63 · 12% of the moat score

Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.

Growth Durability

Score 27 · 8% of the moat score

Growth durability separates an expanding installed base from a good product cycle.

How each Medical Devices & Diagnostics defense is measured, in full →

Understanding MDAI's moat

What is Spectral AI, Inc.'s moat score?

Spectral AI, Inc. (MDAI) scores 42 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #103 of 160 scored companies in Medical Devices, the top 64%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 159 companies in Medical Devices. Its strongest defense is Capital Structure & Resilience (63/100) and its weakest is R&D Pipeline & Capital Returns (9/100).

How does Spectral AI, Inc. compare with other Medical Devices companies?

Spectral AI, Inc. ranks #103 of 160 scored companies in Medical Devices by moat score. The widest moat in Medical Devices is iRadimed Corporation (IRMD) at 83/100. The companies ranked closest are MDAIW (MDAIW) at 42 just above it and Myomo Inc. (MYO) at 41 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 159 companies in Medical Devices. The defenses are then weighted to produce the overall score out of 100.

Why is Spectral AI, Inc. scored with the Medical Devices & Diagnostics template?

Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.

Which competitive defenses are measured for Spectral AI, Inc.?

The Medical Devices & Diagnostics template measures 6 defenses, and MDAI scores: Pricing Power & Consumable Moat (51), R&D Pipeline & Capital Returns (9), FCF Quality & Cash Conversion (52), Commercial Execution (59), Capital Structure & Resilience (63), Growth Durability (27). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000